TrialAnnals of the rheumatic diseases2020

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Elise van Mulligen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.